190 related articles for article (PubMed ID: 38501595)
21. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Lantelme P; Lo M; Sassard J
Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
[TBL] [Abstract][Full Text] [Related]
22. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
[TBL] [Abstract][Full Text] [Related]
23. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
24. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
26. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
Bertram D; Blanc-Brunat N; Sassard J; Lo M
Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1041-5. PubMed ID: 12376396
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
Duke LM; Paull JR; Widdop RE
Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
[TBL] [Abstract][Full Text] [Related]
28. Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt.
Richer-Giudicelli C; Domergue V; Gonzalez MF; Messadi E; Azizi M; Giudicelli JF; Ménard J
J Hypertens; 2004 Mar; 22(3):619-27. PubMed ID: 15076169
[TBL] [Abstract][Full Text] [Related]
29. Differential response of angiotensin peptides in the urine of hypertensive animals.
Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
31. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
32. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
33. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
34. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Campbell DJ; Duncan AM; Kladis A; Harrap SB
J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
[TBL] [Abstract][Full Text] [Related]
35. Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats.
Negishi E; Fukuda N; Otsuki T; Katakawa M; Komatsu K; Chen L; Tanaka S; Kobayashi H; Hatanaka Y; Ueno T; Endo M; Mashimo T; Nishiyama A; Abe M
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1747-F1758. PubMed ID: 30256128
[TBL] [Abstract][Full Text] [Related]
36. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms responsible for postmenopausal hypertension in a rat model: Roles of the renal sympathetic nervous system and the renin-angiotensin system.
Maranon RO; Reckelhoff JF
Physiol Rep; 2016 Feb; 4(2):. PubMed ID: 26811052
[TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Black MJ; Kanellakis P; Bobik A
J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
